Advertisement
Advertisement
U.S. Markets closed
S&P Futures
3,926.25 +3.50 (+0.09%) Dow Futures
31,475.00 +35.00 (+0.11%) Nasdaq Futures
11,927.75 -7.75 (-0.06%) Russell 2000 Futures
1,777.80 +5.00 (+0.28%) Crude Oil
110.59 +1.00 (+0.91%) Gold
1,814.50 -1.40 (-0.08%)
Kodiak Sciences Inc. (KOD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 6.11 |
| Open | 5.94 |
| Bid | 6.35 x 3000 |
| Ask | 6.45 x 900 |
| Day's Range | 5.86 - 6.12 |
| 52 Week Range | 4.90 - 131.97 |
| Volume | |
| Avg. Volume | 1,949,454 |
| Market Cap | 310.304M |
| Beta (5Y Monthly) | 1.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.34 |
| Earnings Date | Feb 28, 2022 - Mar 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19.10 |
- American City Business Journals
Stock rebound uncertain for U.S. biotechs as risks multiply for investors
U.S. biotechs and other health care stocks accounted for about 11% of all losses in U.S. equity values during the five-month period analyzed by The Business Journals.
- Zacks
Kodiak Sciences (KOD) Q1 Loss Widens, Eye Candidate in Focus
Kodiak Sciences (KOD) reports wider-than-expected loss in the first quarter of 2022. Focus is on lead candidate, KSI-301, being developed for treating various retinal vascular diseases.
- Simply Wall St.
Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Invest In Growth?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
